In this interview, Jason Rolfe, Co-Founder and CTO of Variational AI, discusses how foundation models are transforming small-molecule drug discovery. The conversation explores how generative AI platforms like Enki™ can navigate vast chemical space and accelerate the design of novel therapeutics.
